BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37524283)

  • 1. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
    Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
    Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cells.
    Maya S; Sarmento B; Lakshmanan VK; Menon D; Seabra V; Jayakumar R
    Int J Biol Macromol; 2014 Aug; 69():532-41. PubMed ID: 24950310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
    Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
    Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
    Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
    AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Cancer Microenvironment Responsive Glycan Receptor-Targeted Nanoparticles for Gemcitabine Delivery to Benzo[a]pyrene-Induced Lung Cancer Model.
    Kumar K; Verma R; Manjit ; Priya ; Mishra M; Rani V; Chawla R
    AAPS PharmSciTech; 2023 Dec; 25(1):2. PubMed ID: 38114772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer.
    Kumari L; Ehsan I; Mondal A; Al Hoque A; Mukherjee B; Choudhury P; Sengupta A; Sen R; Ghosh P
    J Drug Target; 2023 Jun; 31(5):521-536. PubMed ID: 37010248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and
    Viswanadh MK; Vikas ; Jha A; Reddy Adena SK; Mehata AK; Priya V; Neogi K; Poddar S; Mahto SK; Muthu MS
    Nanomedicine (Lond); 2020 Oct; 15(24):2345-2367. PubMed ID: 32945225
    [No Abstract]   [Full Text] [Related]  

  • 8. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy.
    Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y
    Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
    Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
    J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer.
    Wang XB; Zhou HY
    Biomed Pharmacother; 2015 Mar; 70():123-8. PubMed ID: 25776490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
    Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
    Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery.
    Bhattacharya S; Anjum MM; Patel KK
    Drug Deliv; 2022 Dec; 29(1):1060-1074. PubMed ID: 35363113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer.
    Li Z; Zhu L; Liu W; Zheng Y; Li X; Ye J; Li B; Chen H; Gao Y
    Acta Biomater; 2020 Apr; 107():242-259. PubMed ID: 32151700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR Targeted Redox Sensitive Chitosan Nanoparticles of Cabazitaxel: Dual-Targeted Cancer Therapy, Lung Distribution, and Targeting Studies by Photoacoustic and Optical Imaging.
    Vikas ; Mehata AK; Viswanadh MK; Malik AK; Setia A; Kumari P; Mahto SK; Muthu MS
    Biomacromolecules; 2023 Nov; 24(11):4989-5003. PubMed ID: 37871263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.
    Sandoval MA; Sloat BR; Lansakara-P DS; Kumar A; Rodriguez BL; Kiguchi K; Digiovanni J; Cui Z
    J Control Release; 2012 Jan; 157(2):287-96. PubMed ID: 21871505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer.
    Kim YJ; Baek DS; Lee S; Park D; Kang HN; Cho BC; Kim YS
    Cancer Lett; 2019 Dec; 466():23-34. PubMed ID: 31521695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.
    Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
    BMC Med; 2012 Mar; 10():28. PubMed ID: 22436374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer model.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Mol Pharm; 2014 Oct; 11(10):3515-27. PubMed ID: 25256346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells.
    Patel J; Amrutiya J; Bhatt P; Javia A; Jain M; Misra A
    J Microencapsul; 2018 Mar; 35(2):204-217. PubMed ID: 29542378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.